裕兴科技(08005.HK)就於美国建设IDC第一期订建造协议 料总代价不超过7,100万美元
裕兴科技(08005.HK)公布,於2019年4月4日间接全资附属订立有关於美国建设IDC第一期的建造协议,总代价为6,249.48万美元(下同),由於美国政府为回应2019冠状病毒病大流行而下达居家禁足令,故IDC第一期建设之进度受到负面影响。
第一期工程将於2021年上半年交付。由於建设IDC第一期之进度有所延误,预期就建设IDC第一期应付Concept CSI之代价将有所调整,而公司预期经调整之总代价将不超过7,100万元,於IDC第一期建设完成後,预期集团之收益基础及IDC组合将有所扩大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.